The oral S1P1 and S1P5 receptor agonist drug – now given the trade name Zeposia – was billed as one of the top 2020 drug launches to watch by Clarivate last month, before the COVID-19 outbreak ...

Bristol Myers Squibb (NYSE:BMY) said a Phase 3 study for its drug Zeposia in the treatment of moderate-to-severe active Crohn’s disease failed to meet its primary endpoint of clinical remission ...

Zeposia (ozanimod) is not safe to take while pregnant or breastfeeding. Certain factors, including the risks of fetal harm, may determine whether you can take the drug during this time.

Bristol-Myers Squibb’s Zeposia (ozanimod) is already tipped for blockbuster sales in its first indication – multiple sclerosis – and new data in ulcerative colitis suggests they could climb ...

Zeposia, an ulcerative colitis medication, ran Z The Light, a direct-to-consumer campaign aimed at driving awareness, intent to ask doctors for the brand, prescriptions and brand equity. Summary of ...

I rely on biologics and infusions. I receive Entyvio every four weeks and take Zeposia daily alongside my other medications, which are crucial for managing my Crohn’s, Colitis, IBS, IBD and ...

Bristol Myers BMY announced that a late-stage study on orally-administered Zeposia (ozanimod) in Crohn’s disease (CD) indication failed to achieve its primary endpoint. This late-stage study was ...